Purchase Order HHSN302201700272P

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. for $22,366.00 on July 26, 2017, with an ultimate completion date of August 4, 2017. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside category. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $6,140.00 on March 15, 2018, with ultimate completion on April 14, 2018. Work is performed at North Bethesda, Maryland. The order is a firm fixed price purchase order with no set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $6,141.00 on April 17, 2018, with ultimate completion on May 16, 2018. Performance occurs in North Bethesda, Maryland. The order is priced on a firm fixed price basis with no set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $20,097 on August 29, 2017, for firm fixed price supply of genomic analysis instruments and consumables. Place of performance is North Bethesda, Maryland. The order is scheduled for completion by September 28, 2017. No set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $23,197.50 on September 5, 2019, with ultimate completion on October 4, 2019. Performance takes place in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. for $11,911.50 on December 16, 2019, with completion by February 29, 2020. The order covers genomic testing services and materials, performed in Bethesda, Maryland. This is a firm fixed price commercial acquisition with no set-aside.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $23,852.00 on July 30, 2018. Performance occurs in Pleasanton, California. The order is firm fixed price with an ultimate completion date of July 30, 2018. No set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $24,011.00 on August 3, 2020, under a Total Small Business set-aside for kits to examine patient samples and correlate gene expression changes with disease severity. Work is performed in Pleasanton, California. The order carries a firm fixed price and an ultimate completion date of September 30, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $24,852.00 for drugs and biological materials, with award and completion dates of February 5, 2019. Performance takes place in Pleasanton, California. The order is priced on a firm fixed price basis with no set-aside.</p>

<p>The National Human Genome Research Institute issued a purchase order to 10X Genomics, Inc. on August 27, 2020, for a kit to examine open chromatin on a single cell level, with a ceiling value of $21,867.50. Place of performance is Pleasanton, California. The order was firm fixed price with an ultimate completion date of October 30, 2020.</p>